BioNTech Hits Three-Year Low As Covid Vaccine Sales Plummet 65%, Missing Forecasts BioNTech Hits Three-Year Low As Covid Vaccine Sales Plummet 65%, Missing Forecasts · Investor's Business Daily ALLISON GATLIN March 20, 2024 1 min read BNTX BioNTech stock tumbled Wednesday after the Covid vaccine maker reported light fourth-quarter sales and profit. Continue Reading Terms and Privacy Policy Privacy Dashboard More Info